CD74 and anaplastic large cell lymphoma: To this end, we treated various ALCL and non-ALCL cell lines in vitro with the recently developed antibody-drug conjugate STRO-001, which is composed of an aglycosylated anti-CD74 IgG1 human antibody conjugated to a non-cleavable linker-maytansinoid warhead [42] (Figure 5A and Figure S3).